Super Bowl LIX champion Dallas Goedert of the Philadelphia Eagles shares his journey with plaque psoriasis. After 20 years of ...

That’s because certain genes play a role. Psoriasis is a skin disease that affects about 8 million Americans. It comes in several forms. Plaque psoriasis is the most common. Plaque psoriasis ...

Vyne Therapeutics has dosed the first participant in a randomised Phase Ib clinical trial of VYN202, an oral treatment for moderate-to-severe plaque psoriasis. The double-blind, placebo-controlled ...

A real-world study in Spain finds faster improvements with induction therapy but highlights long-term drug survival ...

A consistent safety profile and sustained efficacy were observed in patients with moderate to severe plaque psoriasis.

QX004N, an interleukin-23 inhibitor, showed safety and efficacy in the treatment of moderate to severe plaque psoriasis, according to a study. QX004N, an IL-23 inhibitor, showed safety and ...